Effects of pioglitazone on the expression of inflammatory cytokines in rat hypertrophic cardiomyocytes

杨维,叶平,周新,伍仕敏,盛莉,陈静,韩春光,刘永学

DOI: https://doi.org/10.3969/j.issn.1009-0126.2006.08.016

2006-01-01

Abstract:Objective To investigate the effects of peroxisome proliferator-activated receptor γ(PPARγ) activator pioglitazone on the expression of inflammatory cytokines in hypertrophic cardio myocytes in vitro.Methods Cardiac hypertrophy was established with angiotensin Ⅱ(AngⅡ) stimulation.Cultured cardiomyocytes were randomly divided into three groups:control group,AngⅡgroup and pioglitazone groups(5 μmol/L,10 μmol/L,20 μmol/L).The mRNA expression of ANP,BNP,IL-1β,IL-6,MMP2,MMP9 and PPARγ were examined by reverse transcription-polymerase chain reaction.The synthetic rate of protein in cardiomyocytes was examined by ~3 H-leucine incorporation and the surface area of cardiomyocyte was analyzed by NIH Image J software.Results Pretreatment of cardiomyocytes with pioglitazone inhibited AngⅡ-induced increase in surface area and ~3 H-leucine incorporation,inhibited the mRNA expression of ANP,BNP,IL-1β,IL-6,MMP2 and MMP9 and increased the expression of PPARγ in hypertrophic cardiomyocytes.All the above effects were related with the dosage of pioglitazone.Conclusions Pioglitazone can inhibit cardiac hypertrophy,which might be related with the effects on the mRNA expression of PPARγ and inflammatory cytokines.